See the PMWC 2026 Speakers
Nobel Laureate
Founder & CEO
Nobel Laureate
FDA Commissioner
Select Speakers:
PMWC 2026 LUMINARY HONOREE
Co-founder & President of OpenAI
Co-founder & President of OpenAI
PMWC 2026 PIONEER HONOREE
Ranked #2 Most Influential Person in Healthcare in 2024
PMWC 2026 SPEAKER
UNEP Entrepreneurial Vision Laureate
PMWC 2026 SPEAKER
*2025 Nobel Laureate
PMWC 2026 LUMINARY HONOREE
Co-founder & Co-CEO of Chan Zuckerberg Initiative
PMWC 2026 SPEAKER
President & CEO of Stanford Health Care
President & CEO of Stanford Health Care
March 4-6 Silicon Valley Program:
From Code to Cure
March 4-6 Silicon Valley Program
Day 1 — March 4
9:00 AM – 5:00 PM
Day 1: Track 1 — Engineered Cell-Based Next-Gen Therapies
Next-Gen Therapies Track
Track Chair: Cindy Perettie, Kite Pharma
PMWC Award Ceremony
- Michel Sadelain, Columbia
- Arie S. Belldegrun, Allogene Therapeutics
Keynote
Engineering the Future: Innovations in CAR-T Therapy Design
- Michel Sadelain, Columbia
CAR-T Cell Therapies: Strategies in Mitigating Challenges in Solid Tumor Delivery
- Chair: David Barrett, Kite
- Carl June, University of Pennsylvania
- Michel Sadelain, Columbia
Tumor-Infiltrating Lymphocytes (TILs): Advances and Challenges in Solid Tumors
- Chair: Allison Betof Warner, Stanford
- George Coukos, Ludwig Institute for Cancer Research
- Max Julve, Royal Marsden
- Stephanie Goff, NIH/NCI
Allogeneic & In Vivo Cell Therapies: Manufacturing & Clinical Progress
- Chair: Arie S. Belldegrun, Allogene Therapeutics
- David Chang, Allogene Therapeutics
- Adrian Bot, Capstan Therapeutics
- Aliya Omer, AstraZeneca
- Priti Hegde, Kite Pharma
Designing Automated Platforms for Scalable Cell Therapy Manufacturing
- Fabian Gerlinghaus, Cellares
TCR-Based Cell Therapies: New Targets and Clinical Advances
- Chair: Diwakar Davar, UPMC
- Lauren Harshman, Clasp Therapeutics
- Cassian Yee, MD Anderson
Gene Editing & Synthetic Biology for Therapy
- Chair: Matthew Porteus, Stanford
- Rachel Haurwitz, Caribou Biosciences
- Kole T. Roybal, Parker Institute
- Ken Drazan, ArsenalBio
Synthetic Circuits for Smarter Cell Therapies: Enhancing NK Precision and Persistence
- Gudrun Stengel, Alida BioSciences
Day 1: Track 2 — AI in Imaging & Predictive Simulation
AI & Computational Medicine Track
Track Chair: Sharat Israni, UCSF
PMWC Award Ceremony Honorees
- Regina Barzilay, MIT
- Joe Petro, Microsoft (Dragon)
- Curtis P Langlotz, Stanford
Scaling AI from Radiology to the Entire Health System
- Joe Petro, Microsoft
From Foundation Models to Digital Twins: AI Reshaping Clinical Imaging
- Chair: Alexander Weir, Canon
- Regina Barzilay, MIT
- Joe Petro, Microsoft
- Curtis P Langlotz, Stanford
Core AI Methods for Precision Medicine Foundation
- Chair: Sharat Israni, UCSF
- James Zou, Stanford
- Regina Barzilay, MIT
- Olivier Gevaert, Stanford
Foundation & Multimodal Models in Precision Medicine
Radiomics & Radiogenomics: Harnessing Precision Imaging for Oncology
- Chair: Chris Hare, Canon Medical
- Ángel Alberich-Bayarri, Quibim
- Kevin Blyth, University of Glasgow
Translational Data Science for Drug Development & Precision Trials
- Chair: Janusz Dutkowski, Data4Cure
AI Digital Twins & Predictive Simulations in Healthcare
Contrast-Free MRI and Low-Dose CT: AI as a Safety Enabler
Clinical Workflow Integration & Decision Support in Imaging
Digital Twins & Predictive Simulation for Therapy Planning
Generative Models for Image Reconstruction & Denoising
Uncertainty & Explainability in Imaging AI for Clinical Adoption
Edge AI for Real-Time Imaging in Scanner & OR Workflows
Multimodal Fusion: Imaging + Omics + EHR for Outcome Prediction
Day 1: Track 3 — Liquid Biopsy – Early Detect. & Screening
Precision Diagnostics Track
Track Chair: Victor Velculescu, Johns Hopkins
PMWC Award Ceremony
- Pioneer Honoree: Klaus Pantel, UKE & ELBS
- Pioneer Honoree: Daniel De Carvalho, University of Toronto
Keynote
- Klaus Pantel, UKE & ELBS
Advancing Minimal Residual Disease (MRD) Detection through cfDNA and cfRNA Profiling
- Chair: Luis Diaz, MSKCC
- Anne-Renee Hartman, Adela
Early Cancer Detection / Regulatory / Population Health
- Peter Bach, DELFI Diagnostics
- Joshua J. Ofman, GRAIL
Role of AI in Liquid Biopsies and Cancer Detection
- Chair: Amoolya Singh, DELFI Diagnostics
Fragmentomics for Early Detection: End Motifs and Library Prep
- Varsha Rao, Claret Bioscience
Clinical Utility of Fragmentomics for Early Cancer Detection
cfDNA Methylation Signatures: From Bench to Clinical Deployment
Exosomes and Extracellular Vesicles: Expanding the Liquid Biopsy Toolbox
Multi-Cancer Early Detection: Defining Value and Managing False Positives
Population-Scale Screening: Designing Trials for Real-World Impact
Integration of Liquid Biopsy with Imaging and Traditional Screening Modalities
Regulatory and Reimbursement Pathways for Early Detection Assays
Standardization of Sample Collection and Pre-Analytical Variables
Beyond Oncology: Liquid Biopsy Applications in Transplant and Infectious Disease
Single-Cell Approaches to Circulating Tumor Analysis
Day 1: Track 4 — Systems Integration & Variant Interpretation
Integrated Precision Medicine Track
PMWC Award Ceremony Honorees
- Mark Daly, Broad Institute
- Gordon Sanghera, Oxford Nanopore
- Howard J. Jacob, Abbvie
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
- Chair: Stephen B. Montgomery, Stanford
- Carlos D. Bustamante, University of Oklahoma
- Mark Daly, Broad Institute/FinnGen
- Manuel Rivas, Stanford
- Mark McCarthy, Genentech
- Nilah Ioannidis, UC Berkeley/UCSC
Biobanks to Bedside: Cutting VUS in Cancer, Cardio & Rare—What’s Working Now
- Chair: Ben Neale, Broad Institute
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
- Chair: Gordon Sanghera, Oxford Nanopore Technologies
- Hanlee P. Ji, Stanford
DNA to Drug, Label & Coverage: From Genetic Signals to Approval & Access
- Russ B Altman, Stanford
- Slavé Petrovski, AstraZeneca
Common Diseases in Clinical Cohorts – Not Always What They Seem
- Howard J. Jacob, Abbvie
DNA to FDA: How Genetic Targets Win Labels & Coverage
- Chair: Razelle Kurzrock, Medical College of Wisconsin
- Russ B Altman, Stanford
25+ Years of the Human Genome — What Made It to the Bedside
- Chair: Ralph Snyderman, Duke
- J. Craig Venter, Craig Venter Institute (JCVI)
- Brook Byers, KPCB
- Lee Hood, Phenome Health
Day 2 — March 5
9:00 AM – 5:00 PM
Day 2: Track 1 — Immunotherapies & Targeted Therapies
Next-Gen Therapies Track
Track Chair: Ira Mellman, Medici Therapeutics
PMWC Award Ceremony
- Jedd D. Wolchok, Weill Cornell Medicine
- Suzanne Topalian, Johns Hopkins
- Levi Garraway, Roche
Targeting the Tumor Microenvironment (TME) in Practice: Biomarkers & Combos
- Chair: Ira Mellman, Medici Therapeutics
- Dmitry Gabrilovich, AstraZeneca
Immunotherapy with Personalized Cancer Vaccines: Who, When, How Fast?
- Chair: Suzanne Topalian, Johns Hopkins
- Tal Zaks, Orbimed
- Lelia Delamarre, Genentech
Fireside Chat: Immune Tolerance to Cure
- Mary E. Brunkow, ISB - 2025 Nobel Laureate
- Lee Hood, Phenome Health
ADCs in the Checkpoint Era: Who Benefits, What to Combine, What to Avoid
- Chair: Shreya Badhrinarayanan, Pfizer
- S. Peter Kang, Daiichi Sankyo
Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
- Janet Xiao, Morrison & Foerster LLP
Checkpoint 2.0 in Practice: PD-1+VEGF Wins, Resistance Salvage & Biomarker Gates
- Chair: Jedd D. Wolchok, Weill Cornell Medicine
- Roy S. Herbst, Yale
Future Breakthroughs in Immuno-Oncology: New Targets, Modalities & Biomarker Decision Gates
- Chair: Levi Garraway, Roche
Day 2: Track 2 — AI in Clinical Decision Support & RWE
AI & Computational Medicine Track
Track Chairs: William Oh, Yale & David Reese, Amgen
PMWC Award Ceremony Honorees
- Nigam Shah, Stanford
Keynote
- David Reese, Amgen
Real-World Evidence & Clinical AI: Closing the Loop Between Data and Care
- Chair: Roxana Daneshjou, Stanford
- Aashima Gupta, Google
- David Sontag, Layer Health
- Brigham Hyde, Atropos Health
- Michael Pfeffer, Stanford
From Data to Decisions: Building Regulatory-Grade RWE from EHR Systems in Oncology
- Chair: Kate Estep, Flatiron Health
AI for Clinical Decision Support: From Models to Bedside
- Chair: Amrita Basu, UCSF
- Anurang Revri, Stanford
- Emily Alsentzer, Stanford
- Okan Ekinci, Roche
AI for CDS: From Models to Bedside
- Zachary Ziegler, OpenEvidence
Operationalizing AI in Health Systems: Trust, Adoption & Outcomes
- Chair: Danton Samuel Char, Stanford
- Matthew Solomon, Sutter Health
- Karan Singhal, Head of Health, OpenAI
- Sina Bari, iMerit Technology
- Hal Paz, Khosla Ventures
Safe, Scalable AI in Clinical Practice: What’s Working and What’s Not
- David Entwistle, CEO, Stanford Health Care
Workflow-First Clinical AI: Integration Patterns, Guardrails & Change Management
- Jorge Duran, Klick Health
From Patient-Generated Data to Regulatory-Grade RWE: Design, Bias & Outcome Linkage
- Greg Bowyer, Evidation
Day 2: Track 3 — Liquid Biopsy – Therapy Guidance & Monitor
Precision Diagnostics Track
Track Chair: Adrian Lee, University of Pittsburgh
PMWC Award Ceremony Honorees
- Dennis J. Slamon, UCLA
Neoadjuvant to Adjuvant MRD: How Early Is Early Enough?
- Chair: Angela DeMichele, UPenn
- Halla Nimeiri, Tempus
- Aparna Parikh, Harvard
- Minetta Liu, Natera
Serial ctDNA-Guided Therapy Switching (SERENA-6 & Beyond)
- Chair: Pedram Razavi, MSK
Rapid MRD to Treatment Decisions: Standardized ctDNA at Scale
- Chair: Luca Quagliata, ThermoFisher
Multi-Omics Monitoring Beyond Variants: Methylation, Fragmentomics, EV/ctRNA
- David T. Miyamoto, Massachusetts General Hospital
- Maximilian Diehn, Stanford
From Validation to Payment: Coverage Pathways That Work
- Mark Stewart, Friends of Cancer Research
- Hilary Gee Goeckner, American Cancer Society (ACS)
- Sally Werner, Cancer Support Community
- Gabriel A. Bien-Willner, Palmetto GBA
Dynamic MRD in Immunotherapy and Cell Therapy Response Assessment
Integration of ctDNA with Imaging and Clinical Biomarkers for Treatment Decisions
Optimizing ctDNA Assays for Minimal Residual Disease in Solid Tumors
MRD for IO & Cell Therapy: Dynamics that Predict Response
ctDNA + Imaging + Clinical Markers: Integrated Response Algorithms
Chasing 10⁻⁵: Optimizing MRD Assays for Solid Tumors
ctDNA + Imaging + Clinical Markers: Integrated Response Algorithms
Chasing 10⁻⁵: Optimizing MRD Assays for Solid Tumors
Tumor-Informed vs Tumor-Agnostic MRD: Showdown with Data
Day 2: Track 4 — Integration & Implementation of Precision Medicine
Integrated Precision Medicine Track
Track Chair: Burns Blaxall
PMWC Award Ceremony Honorees
- Euan Ashley, Stanford
- Jeff Balser, VUMC
Precision Medicine at Scale, Lessons from Vanderbilt
- Jeffrey R. Balser, Vanderbilt
Implementing Precision Medicine at Scale: Health Systems and Policy Perspectives
- Jeffrey Balser, Vanderbilt
- Euan Ashley, Stanford
- Sasa Jenko, European Commission
Keynote: AI- and Data-Driven Individual Health: Optimizing Wellness, Preventing Disease and Empowering Precision Medicine
- Lee Hood, Phenome Health
Keys to Successful Implementation of a Precision Medicine Program
- Chair: Howard McLeod, GeneDx
- David E. Lanfear, Henry Ford Health
- Kevan Simms, Ochsner Health
Key Players in Successful Implementation – Beyond Oncology
- Chair: Damon Hostin, Illumina
- Shaista Malik, UC Irvine
Fireside Chat: From $/Gb to Outcomes - Simplifying Genomics for Health Systems
- Jacob Thaysen, CEO, Illumina
Precision Medicine at Scale: Lessons from a Statewide Genomic Initiative
- Chair: Premal Shah, MyOme
Achieving Comprehensive Precision Medicine
- Chair: Burns Blaxall
- Trish Brown, GeneDx
- Sarah Hersey, BMS
- Euan Ashley, Stanford
Making PM Work: FHIR/OMOP Patterns That Survive Production
Consent, Identity & Data Rights: Trust Infrastructure for PM
Consent, Identity & Data Rights: Trust Infrastructure for PM
Day 3 — March 6
9:00 AM – 4:00 PM
Day 3: Track 1 — RNA, Stem Cell and Gene-Based Therapies
Next-Gen Therapies Track
Track Chair: Catriona Jamieson, UCSD
PMWC Award Ceremony Honorees
- Judy Faulkner, Epic
- Svetlana Mojsov, The Rockefeller University (GLP-1)
- Alexis C. Komor, UCSD
Opening Talk
- Catriona Jamieson, UC San Diego
GLP-1: From Hormone Discovery to a Global Therapeutic Revolution
- Svetlana Mojsov, The Rockefeller University
What’s Next at Epic?
- Peter DeVault, Epic
Modified mRNA, siRNA, ASOs
- Chair: Alexis C. Komor, UC San Diego
- Niren Murthy, UC Berkeley
- Gene Yeo, UC San Diego
- Reuben Harris, UT Health San Antonio
Stem Cell–Targeted Therapeutics: Small Molecules & Biologics
- Chair: Catriona Jamieson, UC San Diego
- Irving L. Weissman, Stanford
In Vivo Gene Therapies
- Chair: Gene Yeo, UC San Diego
- Mark A. Kay, Stanford
- David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
- Chair: Ezra Cohen, Tempus
- Eitan Ruppin, NIH
- David Ledbetter, Florida State University
- Ludmil Alexandrov, UC San Diego
Closing
- Catriona Jamieson, UC San Diego
Programmable RNA Medicines: From Sequence Design to Dosing Windows
Extrahepatic Delivery at Last: LNP, AAV, and Emerging Vectors for Hard-to-Reach Tissues
Splice Editing in the Clinic: When ASOs Beat CRISPR
Off-Targets, On-Target Tox: What Actually Derails RNA & Gene Therapies
CMC for In-Vivo Gene Therapy: Potency, Release, and Stability That Survive the FDA
Extrahepatic Delivery at Last: LNP, AAV, and Emerging Vectors for Hard-to-Reach Tissues
Splice Editing in the Clinic: When ASOs Beat CRISPR
Off-Targets, On-Target Tox: What Actually Derails RNA & Gene Therapies
CMC for In-Vivo Gene Therapy: Potency, Release, and Stability That Survive the FDA
Day 3: Track 2 — AI in Drug Discovery & Computational Bio.
AI & Computational Medicine Track
Track Chairs: Gad Getz, Broad Institute & Alex Morgan, Khosla Ventures
PMWC Award Ceremony Honoree
- Greg Brockman, President & Co-Founder, OpenAI
- Steve Wozniak, Co-Founder, Apple
Fireside Chat
- Vinod Khosla, Khosla Ventures
- Greg Brockman, President & Co-Founder, OpenAI
Target Discovery: Beyond Genomics – Revealing Hidden Layers of Biology with AI
- Keynote: Stephen Quake, CZ Biohub
- Chair: Harlan Robins, Adaptive Biotech
- Aritro Nath, City of Hope
- Massa Shoura, Phinomics
- Omar Serang, DNAnexus
Illuminating Drug Discovery: AI Models That Learn From Biology
- Erwin Estigarribia, HEADLAMP Health
Harmonizing the Data Economy: Enabling AI Across Institutions and Therapeutic Areas
- Noah Nasser, Datma
Systems Integration for
Drug Discovery and AI
- Hugo Lam, Genentech
Can AI Really Create the Next Blockbuster Drug?
- James Zou, Stanford
Interpretable AI for Biomarker Discovery: Accelerating Drug Development
- Chair: Rajat Roy, PATHOMIQ INC
Interpretable AI Models for Multi-Modal Biomarker Discovery in Drug Development
- Vitalay Fomin, Numenos
From Prediction to Translation: AI and In Vivo Validation to Improve Drug
- Gabriel Musso, biosymetrics
Closing the Loop: AI in the Messy Middle of Drug Development
- Ari Caroline, Weave Bio
- Dina Katabi, Emerald / MIT
- Andrei Georgescu, Vivodyne
Is AI the New Drug?
- Michael J. Kahana, Nia Therapeutics
Day 3: Track 3 — Spatial Biology & Single-Cell Multi-Omics
Precision Diagnostics Track
Track Chair: Christina Curtis, Stanford
PMWC Award Ceremony Honoree
- W.E. Moerner, Stanford — Nobel Laureate
- Priscilla Chan, co-founder & co-CEO, Chan Zuckerberg Initiative
- Serge Saxonov, 10x Genomics
Fireside Chat
- Moderator: Christina Curtis, Stanford
- W.E. Moerner, Stanford
- Priscilla Chan, Chan Zuckerberg Initiative
Fireside chat with Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
- Joakim Lundeberg, SciLifeLab
- Garry P. Nolan, Stanford
- Tae Hyun Hwang, Vanderbilt University Medical Center
- Michael Angelo, Stanford
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
- Chair: Christina Curtis, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
- Ash Alizadeh, Stanford
- Alex Aravanis, Moonwalk Biosciences
Personal Omics at Scale, What Longitudinal Profiles Add to Early Detection
- Michael Snyder, Stanford
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
- Chair: Marina Sirota, UCSF
- Olivier Gevaert, Stanford
- Rebecca Critchley-Thorne, Castle Biosciences
Nanomechanical Signatures for Cancer Diagnostics: Insights from Tumor Biophysics
- Chair: Marija Plodinec, Artidis
The Pre-Analytics Playbook for Single-Cell & Spatial Oncology
- Aruna Ayer, BD
Scaling Spatial Genomics for Routine Clinical Discovery
- Jeremy Schurman, Singular Genomics
In Situ Sequencing & FFPE-Compatible Spatial Profiling in Routine Pathology
Day 3: Track 4 — Precision Aging & Precision Longevity
Integrated Precision Medicine Track
Track Chair: Alex Zhavoronkov, Insilico Medicine
PMWC Award Ceremony Honorees
- Steve Horvath, UCLA
- David Sinclair, Harvard
- Nir Barzilai, Albert Einstein College of Medicine
AI & Biomarkers for Measuring Aging
- Chair: Alex Zhavoronkov, Insilico Medicine
- Luigi Ferrucci, NIH
- Sara Hägg, Karolinska Institutet
- Steve Horvath, UCLA
Epigenetic Rejuvenation & Delivery for Clinical Translation
- Ryan (Yuancheng) Lu, Whitehead Institute / MIT
- David Sinclair, Harvard
Clinical Trial Design & Functional Endpoints for Healthspan
- Nir Barzilai, Albert Einstein
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
- S. Jay Olshansky, University of Illinois
Mitochondrial Function and Metabolic Interventions in Healthy Aging
Senolytics and Cellular Senescence: Translating Lab Findings to Patients
Wearable and Digital Biomarkers for Monitoring Aging Interventions
Multi-Omics Approaches to Understanding Biological Aging
Equity and Access in Aging Interventions: Avoiding Healthspan Gaps
Trial-Ready Aging Biomarkers: Surrogate, Clinical, or Just Hype?
Designing Healthspan Trials: Endpoints Payers Will Reimburse
Epigenetic Rejuvenation vs Slowing Aging: Different Goals, Different Evidence
Digital & Wearable Biomarkers for Aging Interventions: Signal, Noise, and Real-World Use
From Blue-Zone Lessons to Health-System Playbooks: Turning Longevity Science into Care
Senolytics and Cellular Senescence: Translating Lab Findings to Patients
Wearable and Digital Biomarkers for Monitoring Aging Interventions
Multi-Omics Approaches to Understanding Biological Aging
Equity and Access in Aging Interventions: Avoiding Healthspan Gaps
Trial-Ready Aging Biomarkers: Surrogate, Clinical, or Just Hype?
Designing Healthspan Trials: Endpoints Payers Will Reimburse
Epigenetic Rejuvenation vs Slowing Aging: Different Goals, Different Evidence
Digital & Wearable Biomarkers for Aging Interventions: Signal, Noise, and Real-World Use
From Blue-Zone Lessons to Health-System Playbooks: Turning Longevity Science into Care
- Select Speakers:
Amanda Acerbi, PharmD
Precision Medicine Global Director
Johnson & Johnson (Janssen)
“I am thrilled to hear about the impressive [2026] lineup of speakers and the engaging topics planned for the conference.”
Amanda Cashin, PhD
Life Science Company Builder & Venture Investor
Wing VC
“Congrats. This is an amazing rock star lineup.”
Tod Klingler, PHD
Founder & CEO
GeneLeap
“I’ve spoken and had exhibitions in the past at PMWC, one of my favorite conferences of the year, and this [2026] year is extra impressive.”
I-Chen Fong, PharmD
Ambulatory Care Pharmacist
Kaiser Permanente
“What an impressive lineup.”
Thomas Wilckens, MD
VP Precision Medicine; ECTT
“There is no other event, with such a lineup of leaders in their field. My annual MUST event since 2013! “
PMWC 2026 Honorees: Pioneer Award
PMWC 2026 PIONEER HONOREE, Immunotherapies & Targeted Therapies Track
PMWC 2026 PIONEER HONOREE, Immunotherapies & Targeted Therapies Track
PMWC 2026 PIONEER HONOREE, Immunotherapies & Targeted Therapies Track
PMWC 2026 PIONEER HONOREE, Therapy Guidance & Monitoring Track
PMWC 2026 PIONEER HONOREE, Integration & Implementation of Precision Medicine Track
PMWC 2026 PIONEER HONOREE, RNA, Stem Cell & Gene-Based Therapies Track
PMWC 2026 PIONEER HONOREE, Precision Aging & Longevity Track
PMWC 2026 PIONEER HONOREE, Systems Integration & Variant Interpretation Track
PMWC 2026 PIONEER HONOREE, RNA, Stem Cell & Gene-Based Therapies Track
PMWC 2026 PIONEER HONOREE NOBEL LAUREATE: Spatial Biology & Single-Cell Multi-Omics Track
PMWC 2026 PIONEER HONOREE
Co-Founder of Apple
Honorees: Luminary Award
PMWC 2026 LUMINARY HONOREE, Advances in Cell & Gene Therapies Track
PMWC 2026 LUMINARY HONOREE, Advances in Cell & Gene Therapies Track
PMWC 2026 LUMINARY HONOREE, AI & Computational Medicine Track
PMWC 2026 LUMINARY HONOREE, Systems Integration & Variant Interpretation Track
PMWC 2026 LUMINARY HONOREE, AI in Clinical Decision Support & RWE Track
PMWC 2026 LUMINARY HONOREE, Integration & Implementation of Precision Medicine Track
PMWC 2026 LUMINARY HONOREE, RNA, Stem Cell & Gene-Based Therapies Track
PMWC 2026 LUMINARY HONOREE, Precision Aging & Longevity Track
PMWC 2026 LUMINARY HONOREE, AI in Drug Discovery & Computational Medicine
PMWC 2026 LUMINARY HONOREE, Precision Aging & Longevity Track
PMWC 2026 LUMINARY HONOREE, Spatial Biology & Single-Cell Multi-Omics Track
PMWC 2026 LUMINARY HONOREE, AI in Clinical Decision Support & RWE Track
Track Chairs
Advances in Cell & Gene Therapies Track Chair
AI in Imaging & Predictive Simulation Track Chair
Liquid Biopsy – Early Detection & Screening Track Chair
Immunotherapies & Targeted Therapies Track Chair
AI in Clinical Decision Support & RWE Track Co-Chair
AI in Clinical Decision Support & RWE Track Co-Chair
Liquid Biopsy – Therapy Guidance & Monitoring Track Chair
Integration & Implementation of Precision Medicine Co-Track Chairs
RNA, Stem Cell and Gene-Based Therapies Track Chair
AI in Drug Discovery & Computational Biology Track Co-Chairs
AI in Drug Discovery & Computational Biology Track Co-Chairs
Spatial Biology & Single-Cell Multi-Omics Track Chair
